Monocyte phenotyping and management of lipoprotein X syndrome

Accumulation of lipoprotein X (LpX) in blood can cause severe hypercholesterolemia and cutaneous xanthomas. Monocytes sensitively sense lipid changes in circulation and contribute to inflammation. However, how monocytes respond to LpX is undefined. We examined the phenotype of monocytes from a patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical lipidology 2020-11, Vol.14 (6), p.850-858
Hauptverfasser: Lian, Zeqin, Saeed, Anum, Peng, Xueying, Perrard, Xiaoyuan Dai, Jia, Xiaoming, Hussain, Aliza, Ballantyne, Christie M., Wu, Huaizhu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 858
container_issue 6
container_start_page 850
container_title Journal of clinical lipidology
container_volume 14
creator Lian, Zeqin
Saeed, Anum
Peng, Xueying
Perrard, Xiaoyuan Dai
Jia, Xiaoming
Hussain, Aliza
Ballantyne, Christie M.
Wu, Huaizhu
description Accumulation of lipoprotein X (LpX) in blood can cause severe hypercholesterolemia and cutaneous xanthomas. Monocytes sensitively sense lipid changes in circulation and contribute to inflammation. However, how monocytes respond to LpX is undefined. We examined the phenotype of monocytes from a patient, who had LpX, severe hypercholesterolemia, and extensive cutaneous xanthomas, and effects of semiselective plasmapheresis therapy (SPPT). Fluorescence-activated cell sorting and adhesion assays were used to examine monocyte phenotype and ex vivo oxidized low-density lipoprotein uptake and adhesion in the patient before and after treatment with SPPT. Effects of plasma from the patient on the phenotype and adhesion of monocytes from a healthy participant were determined. SPPT improved hypercholesterolemia and cutaneous xanthomas. Before treatment, the patient had lower frequency of nonclassical monocytes but higher frequency of intermediate monocytes than the control participant. Before treatment, monocytes from the patient with LpX showed more intracellular lipid accumulation, alterations in several cell surface markers and intracellular cytokines, as well as enhanced oxidized low-density lipoprotein uptake and reduced adhesion compared with control. After SPPT, the phenotypes of monocytes from the patient with LpX were similar to control monocytes. Incubation with plasma from the patient before treatment as compared with plasma from the control participant or the patient after treatment increased CD11c expression and adhesion of monocytes from a healthy participant. LpX-induced hypercholesterolemia increased lipid accumulation and altered the phenotype of monocytes, which may contribute to cutaneous xanthoma development. Removal of LpX by SPPT reduced lipid accumulation and improved monocyte phenotype, likely contributing to xanthoma resolution. •Cutaneous xanthomas presented in a woman with lipoprotein X (LpX)-induced hypercholesterolemia.•LpX-induced hypercholesterolemia increased lipid accumulation in monocytes.•LpX-induced hypercholesterolemia altered phenotypes of circulating monocytes.•Removal of LpX by plasma exchange reduced size of the cutaneous xanthomas.•Removal of LpX by plasma exchange improved monocyte phenotypes.
doi_str_mv 10.1016/j.jacl.2020.08.012
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7736232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1933287420302580</els_id><sourcerecordid>33011137</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-acb884e0f57528af037ada82a2afa178b0acbcfdd48027ab8066897d7511ce883</originalsourceid><addsrcrecordid>eNp9kN1KxDAQhYMorq6-gBfSF2idJG2TBRVk8Q9WvFHwLqRJupuyTUpaF_r2Zlld9MarGZhzzsx8CF1gyDDg8qrJGqnWGQECGfAMMDlAJ5izMs0Znx3GfkZpSjjLJ-i07xuAomBQHKMJpYAxpuwE3bx459U4mKRbGeeHsbNumUink1Y6uTStcUPi62RtO98FPxjrko-kH50OvjVn6KiW696cf9cpen-4f5s_pYvXx-f53SJVeVEMqVQV57mBumAF4bIGyqSWnEgia4kZryAqVK11zoEwWXEoSz5jmhUYK8M5naLbXW73WbVGq3hUkGvRBdvKMAovrfg7cXYlln4jGKMloSQGkF2ACr7vg6n3XgxiC1M0YgtTbGEK4CLCjKbL31v3lh96UXC9E5j4-8aaIHpljVNG22DUILS3_-V_AYFWiAk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Monocyte phenotyping and management of lipoprotein X syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lian, Zeqin ; Saeed, Anum ; Peng, Xueying ; Perrard, Xiaoyuan Dai ; Jia, Xiaoming ; Hussain, Aliza ; Ballantyne, Christie M. ; Wu, Huaizhu</creator><creatorcontrib>Lian, Zeqin ; Saeed, Anum ; Peng, Xueying ; Perrard, Xiaoyuan Dai ; Jia, Xiaoming ; Hussain, Aliza ; Ballantyne, Christie M. ; Wu, Huaizhu</creatorcontrib><description>Accumulation of lipoprotein X (LpX) in blood can cause severe hypercholesterolemia and cutaneous xanthomas. Monocytes sensitively sense lipid changes in circulation and contribute to inflammation. However, how monocytes respond to LpX is undefined. We examined the phenotype of monocytes from a patient, who had LpX, severe hypercholesterolemia, and extensive cutaneous xanthomas, and effects of semiselective plasmapheresis therapy (SPPT). Fluorescence-activated cell sorting and adhesion assays were used to examine monocyte phenotype and ex vivo oxidized low-density lipoprotein uptake and adhesion in the patient before and after treatment with SPPT. Effects of plasma from the patient on the phenotype and adhesion of monocytes from a healthy participant were determined. SPPT improved hypercholesterolemia and cutaneous xanthomas. Before treatment, the patient had lower frequency of nonclassical monocytes but higher frequency of intermediate monocytes than the control participant. Before treatment, monocytes from the patient with LpX showed more intracellular lipid accumulation, alterations in several cell surface markers and intracellular cytokines, as well as enhanced oxidized low-density lipoprotein uptake and reduced adhesion compared with control. After SPPT, the phenotypes of monocytes from the patient with LpX were similar to control monocytes. Incubation with plasma from the patient before treatment as compared with plasma from the control participant or the patient after treatment increased CD11c expression and adhesion of monocytes from a healthy participant. LpX-induced hypercholesterolemia increased lipid accumulation and altered the phenotype of monocytes, which may contribute to cutaneous xanthoma development. Removal of LpX by SPPT reduced lipid accumulation and improved monocyte phenotype, likely contributing to xanthoma resolution. •Cutaneous xanthomas presented in a woman with lipoprotein X (LpX)-induced hypercholesterolemia.•LpX-induced hypercholesterolemia increased lipid accumulation in monocytes.•LpX-induced hypercholesterolemia altered phenotypes of circulating monocytes.•Removal of LpX by plasma exchange reduced size of the cutaneous xanthomas.•Removal of LpX by plasma exchange improved monocyte phenotypes.</description><identifier>ISSN: 1933-2874</identifier><identifier>EISSN: 1876-4789</identifier><identifier>DOI: 10.1016/j.jacl.2020.08.012</identifier><identifier>PMID: 33011137</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Foamy monocyte ; Humans ; Hypercholesterolemia ; Hypercholesterolemia - blood ; Hypercholesterolemia - immunology ; Lipoprotein X ; Lipoprotein-X - blood ; Monocytes - cytology ; Phenotype ; Primary biliary cirrhosis</subject><ispartof>Journal of clinical lipidology, 2020-11, Vol.14 (6), p.850-858</ispartof><rights>2020 National Lipid Association</rights><rights>Copyright © 2020 National Lipid Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-acb884e0f57528af037ada82a2afa178b0acbcfdd48027ab8066897d7511ce883</citedby><cites>FETCH-LOGICAL-c455t-acb884e0f57528af037ada82a2afa178b0acbcfdd48027ab8066897d7511ce883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1933287420302580$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33011137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lian, Zeqin</creatorcontrib><creatorcontrib>Saeed, Anum</creatorcontrib><creatorcontrib>Peng, Xueying</creatorcontrib><creatorcontrib>Perrard, Xiaoyuan Dai</creatorcontrib><creatorcontrib>Jia, Xiaoming</creatorcontrib><creatorcontrib>Hussain, Aliza</creatorcontrib><creatorcontrib>Ballantyne, Christie M.</creatorcontrib><creatorcontrib>Wu, Huaizhu</creatorcontrib><title>Monocyte phenotyping and management of lipoprotein X syndrome</title><title>Journal of clinical lipidology</title><addtitle>J Clin Lipidol</addtitle><description>Accumulation of lipoprotein X (LpX) in blood can cause severe hypercholesterolemia and cutaneous xanthomas. Monocytes sensitively sense lipid changes in circulation and contribute to inflammation. However, how monocytes respond to LpX is undefined. We examined the phenotype of monocytes from a patient, who had LpX, severe hypercholesterolemia, and extensive cutaneous xanthomas, and effects of semiselective plasmapheresis therapy (SPPT). Fluorescence-activated cell sorting and adhesion assays were used to examine monocyte phenotype and ex vivo oxidized low-density lipoprotein uptake and adhesion in the patient before and after treatment with SPPT. Effects of plasma from the patient on the phenotype and adhesion of monocytes from a healthy participant were determined. SPPT improved hypercholesterolemia and cutaneous xanthomas. Before treatment, the patient had lower frequency of nonclassical monocytes but higher frequency of intermediate monocytes than the control participant. Before treatment, monocytes from the patient with LpX showed more intracellular lipid accumulation, alterations in several cell surface markers and intracellular cytokines, as well as enhanced oxidized low-density lipoprotein uptake and reduced adhesion compared with control. After SPPT, the phenotypes of monocytes from the patient with LpX were similar to control monocytes. Incubation with plasma from the patient before treatment as compared with plasma from the control participant or the patient after treatment increased CD11c expression and adhesion of monocytes from a healthy participant. LpX-induced hypercholesterolemia increased lipid accumulation and altered the phenotype of monocytes, which may contribute to cutaneous xanthoma development. Removal of LpX by SPPT reduced lipid accumulation and improved monocyte phenotype, likely contributing to xanthoma resolution. •Cutaneous xanthomas presented in a woman with lipoprotein X (LpX)-induced hypercholesterolemia.•LpX-induced hypercholesterolemia increased lipid accumulation in monocytes.•LpX-induced hypercholesterolemia altered phenotypes of circulating monocytes.•Removal of LpX by plasma exchange reduced size of the cutaneous xanthomas.•Removal of LpX by plasma exchange improved monocyte phenotypes.</description><subject>Foamy monocyte</subject><subject>Humans</subject><subject>Hypercholesterolemia</subject><subject>Hypercholesterolemia - blood</subject><subject>Hypercholesterolemia - immunology</subject><subject>Lipoprotein X</subject><subject>Lipoprotein-X - blood</subject><subject>Monocytes - cytology</subject><subject>Phenotype</subject><subject>Primary biliary cirrhosis</subject><issn>1933-2874</issn><issn>1876-4789</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kN1KxDAQhYMorq6-gBfSF2idJG2TBRVk8Q9WvFHwLqRJupuyTUpaF_r2Zlld9MarGZhzzsx8CF1gyDDg8qrJGqnWGQECGfAMMDlAJ5izMs0Znx3GfkZpSjjLJ-i07xuAomBQHKMJpYAxpuwE3bx459U4mKRbGeeHsbNumUink1Y6uTStcUPi62RtO98FPxjrko-kH50OvjVn6KiW696cf9cpen-4f5s_pYvXx-f53SJVeVEMqVQV57mBumAF4bIGyqSWnEgia4kZryAqVK11zoEwWXEoSz5jmhUYK8M5naLbXW73WbVGq3hUkGvRBdvKMAovrfg7cXYlln4jGKMloSQGkF2ACr7vg6n3XgxiC1M0YgtTbGEK4CLCjKbL31v3lh96UXC9E5j4-8aaIHpljVNG22DUILS3_-V_AYFWiAk</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Lian, Zeqin</creator><creator>Saeed, Anum</creator><creator>Peng, Xueying</creator><creator>Perrard, Xiaoyuan Dai</creator><creator>Jia, Xiaoming</creator><creator>Hussain, Aliza</creator><creator>Ballantyne, Christie M.</creator><creator>Wu, Huaizhu</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20201101</creationdate><title>Monocyte phenotyping and management of lipoprotein X syndrome</title><author>Lian, Zeqin ; Saeed, Anum ; Peng, Xueying ; Perrard, Xiaoyuan Dai ; Jia, Xiaoming ; Hussain, Aliza ; Ballantyne, Christie M. ; Wu, Huaizhu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-acb884e0f57528af037ada82a2afa178b0acbcfdd48027ab8066897d7511ce883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Foamy monocyte</topic><topic>Humans</topic><topic>Hypercholesterolemia</topic><topic>Hypercholesterolemia - blood</topic><topic>Hypercholesterolemia - immunology</topic><topic>Lipoprotein X</topic><topic>Lipoprotein-X - blood</topic><topic>Monocytes - cytology</topic><topic>Phenotype</topic><topic>Primary biliary cirrhosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lian, Zeqin</creatorcontrib><creatorcontrib>Saeed, Anum</creatorcontrib><creatorcontrib>Peng, Xueying</creatorcontrib><creatorcontrib>Perrard, Xiaoyuan Dai</creatorcontrib><creatorcontrib>Jia, Xiaoming</creatorcontrib><creatorcontrib>Hussain, Aliza</creatorcontrib><creatorcontrib>Ballantyne, Christie M.</creatorcontrib><creatorcontrib>Wu, Huaizhu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical lipidology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lian, Zeqin</au><au>Saeed, Anum</au><au>Peng, Xueying</au><au>Perrard, Xiaoyuan Dai</au><au>Jia, Xiaoming</au><au>Hussain, Aliza</au><au>Ballantyne, Christie M.</au><au>Wu, Huaizhu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monocyte phenotyping and management of lipoprotein X syndrome</atitle><jtitle>Journal of clinical lipidology</jtitle><addtitle>J Clin Lipidol</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>14</volume><issue>6</issue><spage>850</spage><epage>858</epage><pages>850-858</pages><issn>1933-2874</issn><eissn>1876-4789</eissn><abstract>Accumulation of lipoprotein X (LpX) in blood can cause severe hypercholesterolemia and cutaneous xanthomas. Monocytes sensitively sense lipid changes in circulation and contribute to inflammation. However, how monocytes respond to LpX is undefined. We examined the phenotype of monocytes from a patient, who had LpX, severe hypercholesterolemia, and extensive cutaneous xanthomas, and effects of semiselective plasmapheresis therapy (SPPT). Fluorescence-activated cell sorting and adhesion assays were used to examine monocyte phenotype and ex vivo oxidized low-density lipoprotein uptake and adhesion in the patient before and after treatment with SPPT. Effects of plasma from the patient on the phenotype and adhesion of monocytes from a healthy participant were determined. SPPT improved hypercholesterolemia and cutaneous xanthomas. Before treatment, the patient had lower frequency of nonclassical monocytes but higher frequency of intermediate monocytes than the control participant. Before treatment, monocytes from the patient with LpX showed more intracellular lipid accumulation, alterations in several cell surface markers and intracellular cytokines, as well as enhanced oxidized low-density lipoprotein uptake and reduced adhesion compared with control. After SPPT, the phenotypes of monocytes from the patient with LpX were similar to control monocytes. Incubation with plasma from the patient before treatment as compared with plasma from the control participant or the patient after treatment increased CD11c expression and adhesion of monocytes from a healthy participant. LpX-induced hypercholesterolemia increased lipid accumulation and altered the phenotype of monocytes, which may contribute to cutaneous xanthoma development. Removal of LpX by SPPT reduced lipid accumulation and improved monocyte phenotype, likely contributing to xanthoma resolution. •Cutaneous xanthomas presented in a woman with lipoprotein X (LpX)-induced hypercholesterolemia.•LpX-induced hypercholesterolemia increased lipid accumulation in monocytes.•LpX-induced hypercholesterolemia altered phenotypes of circulating monocytes.•Removal of LpX by plasma exchange reduced size of the cutaneous xanthomas.•Removal of LpX by plasma exchange improved monocyte phenotypes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33011137</pmid><doi>10.1016/j.jacl.2020.08.012</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1933-2874
ispartof Journal of clinical lipidology, 2020-11, Vol.14 (6), p.850-858
issn 1933-2874
1876-4789
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7736232
source MEDLINE; Elsevier ScienceDirect Journals
subjects Foamy monocyte
Humans
Hypercholesterolemia
Hypercholesterolemia - blood
Hypercholesterolemia - immunology
Lipoprotein X
Lipoprotein-X - blood
Monocytes - cytology
Phenotype
Primary biliary cirrhosis
title Monocyte phenotyping and management of lipoprotein X syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A23%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monocyte%20phenotyping%20and%20management%20of%20lipoprotein%20X%20syndrome&rft.jtitle=Journal%20of%20clinical%20lipidology&rft.au=Lian,%20Zeqin&rft.date=2020-11-01&rft.volume=14&rft.issue=6&rft.spage=850&rft.epage=858&rft.pages=850-858&rft.issn=1933-2874&rft.eissn=1876-4789&rft_id=info:doi/10.1016/j.jacl.2020.08.012&rft_dat=%3Cpubmed_cross%3E33011137%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33011137&rft_els_id=S1933287420302580&rfr_iscdi=true